Infusion of fluids and drugs at very low rates may be necessary in neonatal intensive care. Marked haemodynamic fluctuations occurring during the infusion of inotropes have been shown to be due to the sticking of the plunger in the barrel of syringes used in syringe drivers. The Australian Therapeutic Goods Administration has recommended the use of volumetric or peristaltic pumps in these circumstances. We tested a number of infusion systems and found that 1. some syringes give continuous flow at low rates, and would be suitable for the delivery of inotropes, and 2. some infusion pumps provide non-continuous flow at low rates, and would not be satisfactory for the infusion of inotropes.
We have previously shown that cyclical fluctuations in the blood pressure and heart rate of neonates receiving dopamine infusions from a syringe pump were due to syringe "stiction", or sticking of the plunger in the barrel of plastic syringes'. The syringe sticks when the syringe pump is unable to overcome the force of friction between the syringe plunger and the barrel, resulting in a series of jerky movements and the bolus delivery of infusate. An example of the haemodynamic results of this is shown in Figure l. Haemodynamic fluctuations of this kind may predispose preterm neonates to intraventricular haemorrhage 2 and brain damage due to their impaired autoregulatory ability.
The Therapeutic Goods Administration 3 ,4 has, through the Australian Therapeutic Device Bulletin, suggested several possible solutions to this problem. Firstly, diluting the infusate and increasing the rate of the infusion will maximize the linear speed of the plunger and lessen syringe stiction. However, rates above the recommended minimum of 5 mllhr may be needed to ensure bolus-free delivery with commonly used syringes'. Such rates are not possible in neonates where the need for low infused volumes and multiple infusions makes it common to use rates of 0.5 mllhr to 2.0 mllhr. Secondly, the use of the smallest volume syringe practicable will also increase the linear speed of the plunger and lessen syringe stiction. Thirdly, the Therapeutic Goods Administration recommended the use of other controlling devices, such as volumetric or peristaltic pumps, to deliver inotropes at low flow rates. e 160- This study examined the flow continuity of a number of infusion systems used in neonatal intensive care and assessed their suitability for the delivery of inotropes.
METHODS AND MATERIALS
The types of pumps and giving sets tested, typical of those used in neonatal intensive care, are shown in Table 1 . Flow rate was measured gravimetrically. Water was delivered via a non-compliant extension set for syringe tests, and directly from the giving set for the infusion pump tests, to a 22-gauge needle. The delivered water was collected in a vessel, designed for minimal evaporative loss, on a balance with a resolution of 0.1 mg (Sartorius BA2lOS, Germany). The design of the collection vessel eliminated drop-effects and maintained the tip of the needle at a constant depth, ensuring a constant backpressure. The weight was recorded every two seconds, and corrected for the rate of evaporation found for the apparatus. Systems were tested at flow rates from 0.1 mllhr to 5.0 mllhr, for at least six hours at each rate. The ISO draft standards recommends testing syringe-based infusion systems for two hours at each rate. Fresh syringes were used for each rate in the syringe drivers and were filled by withdrawing the plunger, without first depressing it, as in both syringe types the plunger was packed in the fully depressed position. Single giving sets were used for all rates in the other infusion pumps. All pumps were operated and primed in accordance with the manufacturers' instructions. For this study, flow was regarded as continuous if there was no period of no-flow greater than 60 seconds. This period was chosen because the half-life of dopamine is 2 to 9 minutes in neonates, and a no-flow period of 60 seconds may result in significant changes in dopamine concentration and haemodynamic effect.
The time to reach 951l,10 of the set flow rate was recorded. The overall mean percentage flow error and the maximum variation in flow were calculated for the second hour of the test in accordance with the ISO draft standards. Variation in flow was calculated using the trumpet algorithms. This algorithm uses moving windows with lengths from 30 seconds to 31 minutes passed over the data. For each window the variation in flow is calculated. A trumpet curve is, then, the maximum and minimum flow (expressed as a percentage variation from the set flow rate) found from all observation windows of a given length plotted against the length of the observation window. Thus, a trumpet curve shows the variability of flow rate. An example of the trumpet curve obtained for Ivac 50 ml syringes is shown in Figure 2 . The ISO draft standard requires the reporting of variation in flow for twominute and five-minute observation windows. 
RESULTS
The results of the study are summarized in Tables 2 to 6. All systems, except the Ivac 50 ml syringes, showed non-continuous flow at one or more flow rates. The duration of the longest no-flow period (excluding startup) was 72 minutes for the Terumo 30 ml syringes, 2.4 minutes for the Abbott Lifecare 5000, 1.1 minute for the Ivac Neomate 565, and 30.2 minutes for the AVI Micro 275. Ivac 50 ml syringes exhibited continuous flow with no boluses. Terumo 30 ml syringes and the Abbott Lifecare 5000 delivered discrete boluses with no flow between boluses. The Ivac Neomate 565 and AVI Micro 275 delivered a continuous flow interrupted by periods of no flow.
All systems, except for Terumo 30 ml syringes, took less than 8 minutes to reach 95070 of the set flow rate at all rates studied. The Terumo 30 ml syringes required longer to achieve flow as the flow rate was reduced, taking almost three hours at 0.1 mllhr. No other system showed a clinically significant increased startup delay with reduced flow rate.
All systems had an overall flow rate error of less than 10% for the second hour of the test. At most flow rates the error was less than 2%. The -85.5% error for the Terumo 30 ml syringes at 0.1 mllhr is due to the startup time being 175.1 min, meaning that only a single bolus was recorded during the test period.
As recommended in the ISO draft standard, flow variation has been characterized using two-minute and five-minute observations windows. All systems displayed increasing flow rate variation with decreasing flow rate, and higher variation with a two-minute window than a five-minute window. The Ivac 50 ml syringes, Ivac Neomate 565 and Abbott Lifecare 5000 systems displayed similar flow variation. The AVI Micro 275 gave very high flow variation below 0.5 mllhr due to periods of no flow.
DISCUSSION
This study has shown that non-continuous delivery occurs from several infusion systems when used at low rates. It has been shown previously that the sticking of syringe pistons in the barrel may cause syringe pump malfunction 6 , and compromise the haemodynamic stability of patients receiving infusions of potent vasoactive drugs with a short duration of action, such as inotropes l • The effect of no-flow periods due to infusion pump fill-stroke interruptions has also been found to cause variations in the haemodynamic stability of patients 7. The Therapeutic Goods Administration 3 has suggested the use of peristaltic or volumetric controllers in lieu of syringe pumps for the infusion of inotropes at low rates. This study has shown that there are commonly used peristaltic and volumetric pumps which are not suitable for the delivery of inotropes at low flow rates.
Terumo 30 ml syringes of US manufacture were found to be unsuitable at rates of less than 5 mllhr. Terumo, in the manual for the Terumo Terufusion Syringe Pump, recommend a minimum flow rate to avoid intermittent infusion, of 10 mllhr for their 30 ml syringes. The instruction manual for the Atom 235 syringe pump does not carry such a warning, despite being calibrated for use with Terumo syringes. These syringes had a significant delay before commencement of flow after the start of the infusion, due to the drive mechanism needing to build up sufficient force to initiate movement of the plunger, i.e. to overcome the so-called breakfree forceS. It is not due to mechanical slack or inadequate priming.
The Ivac 50 ml syringes were suitable for use down to 0.1 mllhr. These syringes had a much lower breakfree force and did not have a long delay before the commencement of the infusion. The manual for the Ivac P3000 recommends rates above 1.0 mllhr for applications where flow continuity is of concern. Where Ivac 50 ml syringes are used, this recommendation appears conservative.
There were significant differences in the flow continuities of the three infusion pumps studied. All had little or no delay between commencement of the infusion and the start of flow. The Abbott Lifecare 5000 gave continuous flow at rates above 0.2 mllhr. This pump draws in 0.33 ml of fluid each fill-cycle and delivers a series of 4.2 Jil boluses (79 boluses/0.33 ml). At less than 0.3 mllhr there needs to be more than 60 seconds between each 4.2 Jil bolus. At 0.1 mllhr this no-flow period is 2.4 minutes.
The Ivac Neomate 565 is a linear peristaltic pump. It has low overall percentage error for the second hour of the test, but high short-term variation at rates below 0.5 mllhr. This variation is due to the delivery of discrete boluses with periods of no flow. At 0.1 mllhr the pump delivers a 1.8 Jil bolus every 1.1 minutes.
Based on data from these tests, the AVI Micro 275 pump has a fill volume of 1.96 ml. The refill cycle takes more than 5 minutes at 1 mllhr and almost 30 minutes at 0.2 mllhr. The extended fill time is responsible for the high overall and short-term variations of this pump. The time between refills must also be considered at low rates. At 0.1 mllhr the pump will only refill every 19.6 hours, and the effect may not be seen during tests or during short periods of operation.
The ISO draft standardS, used as a basis for the calculations in this study, was designed for syringebased pumps and uses the second hour of the infusion for variability calculations. It has previously been shown that syringes may change their characteristics after a period of operation, or may display different characteristics depending on the location of the plunger in the barrel l • Long startup times at low flow rates will invalidate the second hour as being characteristic of the overall performance of the syringe: for example at 0.1 mllhr Terumo 30 ml syringes did not begin flowing until 4.9 minutes before the end of the analysis Anaesthesia and Intensive Care, Vol. 23, No. 5, October 1995 period. Therefore, data from only the second hour may not be sufficient to fully characterize the flow continuity. This problem is also true for pumps which employ a fill-stroke. At low rates the fill-stroke may not occur during the second hour of the test, and the true characteristics of the pump may not be seen.
In order to fully characterize an infusion system, we recommend that, for a given flow rate, a flow continuity test should continue until at least three fillstrokes are recorded, or, in the case of syringe pumps, for at least the period a single syringe would be used clinically. Analysis of the data at each flow rate should include the time to commencement of flow, time between fill-strokes, length of no-flow periods (whether due to fill-strokes or between boluses), size of any boluses delivered, long-term flow rate accuracy, and short-term flow rate accuracy both during normal operation, and around a fill-stroke. Trumpet curves should only be constructed from a data segment characteristic of the overall performance of the system. Given the data obtained from these tests, a decision can then be made as to the suitability of the pump for the delivery of particular drugs such as potent vasoactive drugs with a short half-life.
CONCLUSION
We have shown that there is considerable variation in flow continuity between infusion systems commonly used for infusions at low rates in neonatal intensive care. There are syringes that give continuous flow at 0.1 mllhr, and infusion pumps which do not. Ivac syringes performed satisfactorily and are suitable for inotropic infusions, whereas Terumo syringes are not suitable. Of the infusion pumps tested, the Abbott Lifecare 5000 and Ivac Neomate 565 would be suitable, but the AVI Micro 275 would not.
Anaesthesia and Intensive Care, Vol. 23, No. 5, October 1995 The recommendation of the Therapeutic Goods Administration to replace syringe drivers with volumetric or peristaltic pumps to deliver inotropes at low rates has been shown to be inappropriate in some cases.
It is recommended that all infusion systems be evaluated prior to use for applications in which flow continuity is important. Regulatory bodies could undertake these tests themselves, or require manufacturers to provide appropriate and comprehensive test data.
Users of infusion systems must be aware that significant differences exist with respect to flow continuity, particularly at low infusion rates, and that noncontinuous delivery of potent drugs with a short halflife may result in haemodynamic instability.
